tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Carl Zeiss Meditec’s New IOL Study: A Potential Game-Changer in Cataract Treatment
PremiumCompany AnnouncementsCarl Zeiss Meditec’s New IOL Study: A Potential Game-Changer in Cataract Treatment
3M ago
Hold Rating for Carl Zeiss Meditec Amid Optimistic Chinese Market Outlook and Operational Challenges
Premium
Ratings
Hold Rating for Carl Zeiss Meditec Amid Optimistic Chinese Market Outlook and Operational Challenges
9M ago
0DHC Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
0DHC Earnings this Week: How Will it Perform?
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100